CVS vs VCEL · P/E 16, rev $402.07B vs P/E 835, rev $237.2M
CVS Health Corp (CVS) versus Vericel Corp Ord (VCEL) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Vericel Corp Ord (VCEL) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported VCEL revenue for 2024-12-31 was $237.2M. Net income was $10.4M. Revenue was up 20.1% from 2023-12-31 to 2024-12-31. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. VCEL currently screens at market cap $2.10B and trailing P/E 834.8.
Not investment advice. Open the CVS and VCEL stock pages for the full models.
Not investment advice.